Abbott Laboratories (ABT): C’est La Vie, AbbVie!
From Insider Monkey - Free Hedge Fund and Insider Trading Data
January 30, 2013 - 3:53pm
Wall Street can’t generate enthusiasm yet for AbbVie Inc (NYSE:ABBV), the recently spun-off pharmaceutical division of Abbott Laboratories (NYSE:ABT), so why do our Motley Fool CAPS members disagree? More than 100 members of the investor-driven community have weighed in on its prospects already — the spinoff was effective Jan. 1 — and all but three [...]
Continue reading this article »
Share This Article: